Eastern and South-Eastern Asia vs North Macedonia: Percentage of bloodstream infection due to Escherichia coli resistant
Eastern and South-Eastern Asia
41.4%
in 2022
North Macedonia
60.0%
in 2022
Eastern and South-Eastern Asia rank
12th
North Macedonia rank
11th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Eastern and South-Eastern Asia
- North Macedonia
How they compare
North Macedonia currently reports 60.0% against 41.4% in Eastern and South-Eastern Asia, a difference of 18.6%.
That makes North Macedonia's figure about 1.5 times Eastern and South-Eastern Asia's.
Across all 6 years both countries report, North Macedonia has been ahead every year.
Eastern and South-Eastern Asia ranks 12th and North Macedonia ranks 11th of 16 groups.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eastern and South-Eastern Asia | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 35.6% | 72.0% | 36.4% | North Macedonia |
| 2020s | 39.4% | 55.6% | 16.2% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Eastern and South-Eastern Asia or North Macedonia?
- North Macedonia, at 60.0% against 41.4% in Eastern and South-Eastern Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Eastern and South-Eastern Asia and North Macedonia?
- 18.6%, with North Macedonia ahead.
- How many years of comparable data are there for Eastern and South-Eastern Asia and North Macedonia?
- 6 years are reported by both, from 2016 to 2022.
- How do Eastern and South-Eastern Asia and North Macedonia rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Eastern and South-Eastern Asia ranks 12th and North Macedonia ranks 11th of 16 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.